References

The Revised Authoritative Guide To Vaccine Legal Exemptions

Vaccines Have Serious Side Effects

Get Instant Access

1. Dowell SF, Schwartz B. Resistant pneumococci: protecting patients through judicious use of antibiotics. Am Fam phys 1997; 55:1647-1654.

2. Arason VA, Kristinsson KG, Sigurdsson JA, Stefansdottir G, Molstad S, Gudmundsson S. Do antimicrobials increase the carriage of penicillin resistant pneumococci in children? Cross sectional prevalence study. Br Med J 1996; 313:387-391.

3. Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci USA 1999; 96:1152-1156.

4. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory physicians. JAMA 1997; 278:901-904.

5. Seppala H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 1997; 337:441-446.

6. Stephenson J. Icelandic researchers are showing the way to bring down rates of antibiotic-resistant bacteria. JAMA 1996; 275:175-176.

7. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 1995; 273:214-219.

8. Mainous AG III, Hueston WJ, Eberlein C. Colour of respiratory discharge and antibiotic use. Lancet 1997; 350:1077.

9. Mainous AG, MacFarlane LL, Connor MK, Green LA, Fowler K, Hueston WJ. Survey of clinical pharmacists' knowledge of appropriateness of antimicrobial therapy for upper respiratory infections and acute bronchitis. Pharmacotherapy 1999; 19:388-392.

10. Mainous AG III, Zoroob RJ, Oler MJ, Haynes DM. Patient knowledge of upper respiratory infections: implications for antibiotic expectations and unnecessary utilization. J Fam Pract 1997; 45:75-83.

11. Dowell SF, Schwartz B, Phillips WR. Appropriate use of antibiotics for URIs in children: Part I. Otitis media and acute sinusitis. The Pediatric URI Consensus Team. Am Family Phys 1998; 58:1113-1118.

12. Dowell SF, Schwartz B, Phillips WR. Appropriate use of antibiotics for URIs in children: Part II. Cough, pharyngitis and the common cold. The Pediatric URI Consensus Team. Am Fam Phys 1998; 58:1335-1342.

13. Otitis Media Guideline Panel. Clinical practice guidelines; otitis media with effusion in young children: Rockville, MD: Agency for Health Care Policy and Research, 1994 (Report No. 94-0622).

14. Bisno AL, Gerber MA, Gwaltney JM, Kaplan EL, Schwartz RH. Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Clin Infect Dis 1997; 25:574-583.

15. Neiderman MS, Bass JB, Campbell GD, Fein AM, Grossman RF, Mandell LA, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis 1993; 149:1418-1426.

16. Butler CC, Rollnick S, Pill R, Maggs-Rapport F, Stott N. Understanding the culture of prescribing: qualitative study of general practitioners' and patients' perceptions of antibiotics for sore throats. Br Med J 1998; 317:637-642.

17. Belongia EA, Schwartz B. Strategies for promoting judicious use of antibiotics by doctors and patients. Br Med J 1998; 317:668-671.

18. Straelens MJ. The epidemiology of antimicrobial resistance in hospital acquired infections: problems and possible solutions. Br Med J 1998; 317:652-654.

19. Society for Healthcare Epidemiology of American and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance. Guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol 1997; 18:275-291.

20. Bero LA, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thomson MA and the Cochrane Effective Practice and Organisation of Care Review Group. Getting research findings into practice. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. Br Med J 1997; 317:465-468.

21. Davis DA, Thomson MA, Oxman AD, Haynes RB. Evidence for the effectiveness of CME: a review of 50 randomized controlled trials. JAMA 1992; 268:1111-1117.

22. O'Connell DL, Henry D, Tomlins R. Randomised controlled trial of effect of feedback on general practitioners'prescribing in Australia. Br Med J 1999; 318:507-511.

23. Ornstein SM, MacFarlane LL, Jenkins RG, Pan Q, Wager KA. Medication cost information in a computer-based patient record system: impact on prescribing in a family medicine clinical practice. Arch Fam Med 1999; 8:118-121.

24. Avorn J, Soumerai SB. Improving drug-therapy decisions through educational outreach. N Engl J Med 1983; 308:1457-1463.

25. Soumerai SB, Avorn J. Principles of educational outreach ("academic detailing") to improve clinical decision making. JAMA 1990; 263:549-556.

26. Headrick LA, Speroff T, Pelecanos HI, Cebul RD. Efforts to improve compliance with the National Cholesterol Education Program guidelines. Results of a randomized controlled trial. Arch Intern Med 1992; 152:2490-2496.

27. Schaffner W, Ray WA, Federspiel CF, Miller WO. Improving antibiotic prescribing in office practice. A controlled trial of three educational methods. JAMA 1983; 250:1728-1732.

28. Geiger WJ, Neuberger MJ, Bell GC. Implementing the US preventive services guidelines in a family practice residency. Fam Med 1998; 25:447-451.

29. Fox CH, Mahoney MC. Improving diabetes preventive care in a family practice residency program: a case study in continuous quality improvement. Fam Med 1998; 30:441-445.

30. Davis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA 1995; 274:700-705.

31. Lohr KN, Brook RH, Kaufman MA. Quality of care in the New Mexico Medicaid program (1971-1975): the effect of the New Mexico Experimental Medical Care Review Organization on the use of antibiotics for common infectious diseases. Med Care 1979; 18:1-129.

32. Mason WH. Strategies to promote appropriate antimicrobial use. Pediatr Infect Dis J 1998; 17:747-748.

33. Lesar TS, Briceland LL. Survey of antibiotic control policies in university-affiliated teaching institutions. Ann Pharmacother 1996; 30:31-34.

34. Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer S, Maurer J. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 1998; 280:1233-1237.

35. Fraise AP. Guidelines for the control of methacillin-resistant Staphylococcus aureus. J Antimi-crob Chemother 1998; 42:287-289.

36. Goeckner BJ, Henderson E, Scott K, Drake M. A vancomycin monitoring program at a community hospital. Joint Commis J Qual Improve 1998; 24:379-385.

37. Evans RS, Pestotnik SL, Classen DC, Clemmer TP, Weaver LK, Orme JF, et al. A computer assisted management program for antibiotics and other antiinfective agents. N Engl J Med 1998; 338:232-238.

38. DeSantis G, Harvey KJ, Howard D, Mashford ML, Moulds RFW. Improving the quality of antibiotic prescription patterns in general practice. The role of educational intervention. Med J Aust 1994; 160:502-505.

39. Ekedahl A, Andersson SI, Hovelius B, Molstad S, Leidholm H, Melander A. Drug prescription attitudes and behavior of general practitioners. Effects of a problem-oriented educational programme. Eur J Clin Pharmacol 1995; 47:381-387.

40. Woolf SH. Practice guidelines: a new reality in medicine: I. Recent developments. Arch Intern Med 1990; 150:1811-1818.

41. Grimshaw JM, Fussell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993; 342:1317-1322.

42. Greco PJ, Eisenberg JM. Changing physicians' practices. N Engl J Med 1993; 329:1271-1274.

43. Rhew DC, Riedinger MS, Sandhu M, Bowers C, Greengold N, Weingarten SR. A prospective, multicenter study of a pneumonia practice guideline. Chest 1998; 114:115-119.

44. O'Connor PJ, Solberg LI, Christianson J, Amundson G, Mosser G. Mechanism of action and impact of a cystitis clinical practice guideline on outcomes and costs of care in an HMO. Joint Commis J Qual Improve 1996; 22:673-682. Oct.

45. Cates C. An evidence based approach to reducing antibiotic use in children with acute otitis media: controlled before and after study. Br Med J 1999; 318:715-716.

46. Glasziou PP, Hayem M, Del Mar CB. Antibiotic versus placebo for acute otitis media in children. In: Cochrane Collaboration. Cochrane Library Issue I. Oxford: Update Software, 1997.

47. Gonzales R, Steiner JF, Lum A, Barrett PH. Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA 1999; 281:1512-1519.

48. Anon. Progress toward eliminating Haemophilus influenzae type b disease among infants and children—United States, 1987-1997. MMWR 1998; 47:993-998.

49. Butler JC, Dowell SF, Breiman RF. Epidemiology of emerging pneumococcal drug resistance: implications for treatment and prevention. Vaccine 1998; 16:1693-1697.

50. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997; 46 (no. RR-8):1-24.

52. Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination coverage levels among persons aged 65 years—United States, 1973-1993. MMWR 1995; 44:506-507, 513-515.

53. Healthy people 2000: national health promotion and disease prevention objectives. Washington, DC: US Department of Health and Human Services, 1991.

54. Fiebach N, Beckett W. Prevention of respiratory infections in adults. Influenza and pneumococ-cal vaccines. Arch Intern Med 1994; 2154:2545-2557.

55. Robbins JB, Lee CH, Rastogi SC, et al. Comparative immunogeneity of group 6 pneumococcal type 6A(6) and type 6B (26) capsular polysaccharides. Infect Immun 1979; 26:1116-1122.

56. Lund BC, Ernst EJ, Klepser ME. Strategies in the treatment of penicillin-resistant Streptococcus pneumoniae. Am J Health Syst Pharm 1998; 55:1987-1994.

57. ASHP Commission on Therapeutics. ASHP therapeutic position statement on strategies for identifying and preventing pneumococcal resistance. Am J Health Syst Pharm 1997; 54:575-578.

58. Sohn YM. Use of vaccine in the era of antimicrobial resistance: need of effective pneumococcal vaccines. Yonsei Med J 1998; 39:611-618.

59. Fine MJ, Smith MA, Carson CA, Meffe F, Sankey SS, Weissfeld LA, Detsky AS, Kapoor WN. Efficacy of pneumococcal vaccination in adults: a meta-analysis of randomized controlled trials. Arch Intern Med 1994; 154:2666-2677.

60. Schwartz B, Bell DM, Hughes JM. Preventing the emergence of antimicrobial resistance. A call for action by clinicians, public health officials, and patients. JAMA 1997; 278:944.

Was this article helpful?

0 0
Dealing With Bronchitis

Dealing With Bronchitis

If you're wanting to know more about dealing with bronchitis... Then this may be the most important letter you'll ever read! You are About To Read The Most Important Information That Is Available To You Today, You Will Achieve A Better Understanding About Bronchitis! It doesn't matter if you've never had bronchitis before or never known anyone who has, This guide will tell you everything you need to know, without spending too much brainpower!

Get My Free Ebook


Post a comment